Regulacje i polityka gospodarcza · 28/09/2018
National Cancer Institute to Grant Exclusive Patent License to Tailored Therapeutics for Cancer Cell Therapies
The National Cancer Institute, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to Tailored Therapeutics, LLC, for the development and commercialization of cancer cell therapies.